CBI books drug firm for causing loss to health dept

The company got medicine supply contract through dubious means

yash

Yash Vardhan Shukla | February 27, 2012



The Central Bureau of Investigation has registered a case against Astrazeneca pharmaceutical company which, through its director and other government and private officials, allegedly caused a loss of Rs 10 crore to the state health department. The agency has also registered a case against unknown officials of Central Procurement Agency (CPA) and Directorate of Health Service (DHS) of the Delhi government.

The CPA and the DHS had allegedly entered into Rate Contract (RC) with a private pharmaceutical company for procurement of Meropenem in 2009. Its procurement rate was fixed at Rs 1,530 plus Vat charges. The company submitted a false affidavit that none of the government, semi-government, autonomous company, public sector undertakings, hospitals, institutions and organisations got the Meropenem medicine at a lower than this rate. The company had got the supply contract through dubious means.

A show cause notice was issued to Astrazeneca by the Chief Medical Officer for recovery of Rs 7.5 crore. The company charged more from the DHS for the same medicine as compared to other agencies and authorised dealers. However, due to the connivance among the company and CPA officials, recovery proceedings were cancelled and DHS continued to purchase the medicines at a higher rate. 

The agency raided the premises of Astrazeneca in New Delhi and Bangalore. It also raided the office of CPA and DHS. It got several documents including files, hard disk, etc, which are being examined.
 

Comments

 

Other News

“Indians, yet treated like outsiders”

Moving to Delhi-NCR for education can be an exciting experience for students from Northeast India. It gives us a chance to meet new people, experience a different culture and become more independent. But living away from home also comes with challenges that people who have not experienced them may not al

Import duty on major edible oils cut

The government has reduced the Basic Customs Duty (BCD) on major imported crude edible oils with a view to moderating domestic edible oil prices, providing relief to consumers and mitigating inflationary pressures arising from the sharp increase in international edible oil prices.  

From pyramid to platform: BRICS agenda for Global South

In his opening address at the 18th BRICS Summit in New Delhi on September 12, prime minister Narendra Modi did something India`s diplomacy has been building towards for three years: he moved the ‘Voice of the Global South’ from a slogan to a work plan. Addressing the leaders, he argued that t

How to realise the full transformative potential of PM-JAY

The Pradhan Mantri Jan Arogya Yojana (PM-JAY), a welfare scheme which covers approximately 45 crore beneficiaries across India, provides cashless health cover of Rs. 5 lakh per family per year. It is the largest health insurance scheme which helped crores of poor families by reducing out-of-pocket expend

The missing men in India`s family planning story

Every pregnancy requires two people. Yet India`s family planning programme continues to ask only one of them to bear almost all of its medical consequences. The newly released National Family Health Survey-6 (2023-24) confirms just how entrenched this asymmetry remains: 36.5% of currently married women a

`Development must be judged beyond GDP, with rights and justice at core`

Delivering the IXth Chief Justice M.C. Chagla Memorial Lecture on ‘Human Rights and Sustainable Development Goals’, in Mumbai Friday,  former Chief Justice of India Bhushan R. Gavai questioned whether conventional economic indicators such as gross domestic product (GDP), national income,

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter